Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | 指定難病告示番号 |
---|---|---|---|---|---|
1 | African trypanosomiasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
2 | African trypanosomiasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
3 | African trypanosomiasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
4 | African trypanosomiasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
5 | African trypanosomiasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
6 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
7 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
8 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
9 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
10 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
11 | Alcoholic liver disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
12 | Alcoholic liver disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
13 | Alcoholic liver disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
14 | Alcoholic liver disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
15 | Alcoholic liver disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
16 | Alzheimer disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
17 | Alzheimer disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
18 | Alzheimer disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
19 | Alzheimer disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
20 | Alzheimer disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
21 | Amoebiasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
22 | Amoebiasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
23 | Amoebiasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
24 | Amoebiasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
25 | Amoebiasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
26 | C-type lectin receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
27 | C-type lectin receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
28 | C-type lectin receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
29 | C-type lectin receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
30 | C-type lectin receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
31 | Chagas disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
32 | Chagas disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
33 | Chagas disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
34 | Chagas disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
35 | Chagas disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
36 | Coronavirus disease - COVID-19 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
37 | Coronavirus disease - COVID-19 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
38 | Coronavirus disease - COVID-19 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
39 | Coronavirus disease - COVID-19 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
40 | Coronavirus disease - COVID-19 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
41 | Cytokine-cytokine receptor interaction 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
42 | Cytokine-cytokine receptor interaction 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
43 | Cytokine-cytokine receptor interaction 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
44 | Cytokine-cytokine receptor interaction 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
45 | Cytokine-cytokine receptor interaction 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
46 | Cytosolic DNA-sensing pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
47 | Cytosolic DNA-sensing pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
48 | Cytosolic DNA-sensing pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
49 | Cytosolic DNA-sensing pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
50 | Cytosolic DNA-sensing pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
51 | Fluid shear stress and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
52 | Fluid shear stress and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
53 | Fluid shear stress and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
54 | Fluid shear stress and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
55 | Fluid shear stress and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
56 | Graft-versus-host disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
57 | Graft-versus-host disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
58 | Graft-versus-host disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
59 | Graft-versus-host disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
60 | Graft-versus-host disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
61 | Hematopoietic cell lineage 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
62 | Hematopoietic cell lineage 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
63 | Hematopoietic cell lineage 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
64 | Hematopoietic cell lineage 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
65 | Hematopoietic cell lineage 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
66 | Herpes simplex virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
67 | Herpes simplex virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
68 | Herpes simplex virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
69 | Herpes simplex virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
70 | Herpes simplex virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
71 | Human cytomegalovirus infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
72 | Human cytomegalovirus infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
73 | Human cytomegalovirus infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
74 | Human cytomegalovirus infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
75 | Human cytomegalovirus infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
76 | IL-17 signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
77 | IL-17 signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
78 | IL-17 signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
79 | IL-17 signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
80 | IL-17 signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
81 | Inflammatory bowel disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
82 | Inflammatory bowel disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
83 | Inflammatory bowel disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
84 | Inflammatory bowel disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
85 | Inflammatory bowel disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
86 | Inflammatory mediator regulation of TRP channels 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
87 | Inflammatory mediator regulation of TRP channels 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
88 | Inflammatory mediator regulation of TRP channels 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
89 | Inflammatory mediator regulation of TRP channels 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
90 | Inflammatory mediator regulation of TRP channels 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
91 | Influenza A 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
92 | Influenza A 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
93 | Influenza A 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
94 | Influenza A 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
95 | Influenza A 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
96 | Legionellosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
97 | Legionellosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
98 | Legionellosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
99 | Legionellosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
100 | Legionellosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
101 | Leishmaniasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
102 | Leishmaniasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
103 | Leishmaniasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
104 | Leishmaniasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
105 | Leishmaniasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
106 | Lipid and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
107 | Lipid and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
108 | Lipid and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
109 | Lipid and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
110 | Lipid and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
111 | Malaria 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
112 | Malaria 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
113 | Malaria 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
114 | Malaria 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
115 | Malaria 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
116 | MAPK signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
117 | MAPK signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
118 | MAPK signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
119 | MAPK signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
120 | MAPK signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
121 | Measles 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
122 | Measles 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
123 | Measles 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
124 | Measles 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
125 | Measles 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
126 | Necroptosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
127 | Necroptosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
128 | Necroptosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
129 | Necroptosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
130 | Necroptosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
131 | NF-kappa B signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
132 | NF-kappa B signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
133 | NF-kappa B signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
134 | NF-kappa B signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
135 | NF-kappa B signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
136 | NOD-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
137 | NOD-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
138 | NOD-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
139 | NOD-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
140 | NOD-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
141 | Non-alcoholic fatty liver disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
142 | Non-alcoholic fatty liver disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
143 | Non-alcoholic fatty liver disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
144 | Non-alcoholic fatty liver disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
145 | Non-alcoholic fatty liver disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
146 | Osteoclast differentiation 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
147 | Osteoclast differentiation 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
148 | Osteoclast differentiation 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
149 | Osteoclast differentiation 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
150 | Osteoclast differentiation 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
151 | Pathogenic Escherichia coli infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
152 | Pathogenic Escherichia coli infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
153 | Pathogenic Escherichia coli infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
154 | Pathogenic Escherichia coli infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
155 | Pathogenic Escherichia coli infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
156 | Pathways of neurodegeneration - multiple diseases 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
157 | Pathways of neurodegeneration - multiple diseases 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
158 | Pathways of neurodegeneration - multiple diseases 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
159 | Pathways of neurodegeneration - multiple diseases 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
160 | Pathways of neurodegeneration - multiple diseases 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
161 | Pertussis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
162 | Pertussis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
163 | Pertussis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
164 | Pertussis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
165 | Pertussis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
166 | Prion disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
167 | Prion disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
168 | Prion disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
169 | Prion disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
170 | Prion disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
171 | Rheumatoid arthritis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
172 | Rheumatoid arthritis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
173 | Rheumatoid arthritis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
174 | Rheumatoid arthritis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
175 | Rheumatoid arthritis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
176 | Salmonella infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
177 | Salmonella infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
178 | Salmonella infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
179 | Salmonella infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
180 | Salmonella infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
181 | Shigellosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
182 | Shigellosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
183 | Shigellosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
184 | Shigellosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
185 | Shigellosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
186 | Th17 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
187 | Th17 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
188 | Th17 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
189 | Th17 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
190 | Th17 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
191 | TNF signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
192 | TNF signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
193 | TNF signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
194 | TNF signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
195 | TNF signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
196 | Toll-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
197 | Toll-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
198 | Toll-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
199 | Toll-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
200 | Toll-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
201 | Tuberculosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
202 | Tuberculosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
203 | Tuberculosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
204 | Tuberculosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
205 | Tuberculosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
206 | Type I diabetes mellitus 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
207 | Type I diabetes mellitus 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
208 | Type I diabetes mellitus 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
209 | Type I diabetes mellitus 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
210 | Type I diabetes mellitus 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
211 | Yersinia infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Canakinumab Canakinumab 💬
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
212 | Yersinia infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Gevokizumab Gevokizumab 💬
| Gevokizumab | 041 4件: 41, 50, 56, 269 💬
|
213 | Yersinia infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Lutikizumab Lutikizumab 💬
| Lutikizumab | 046 3件: 46, 96, 97 💬
|
214 | Yersinia infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
215 | Yersinia infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B 1件: IL1B 💬
|
Rilonacept Rilonacept 💬
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|